Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

g-csf

g-csf is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 3
Pipeline programs 9
News articles 0
Drug details — g-csf
Class
—
Route
—
Patents
3
Programs
9
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

g-csf is an FDA-listed pharmaceutical active ingredient.

Key facts

INN g-csf

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. DAC-HAAG-02 Phase 3 · Hospital Authority · Acute Myeloid Leukemia
  2. Decitabine Phase 3 · Chinese Academy of · Myelodysplastic Syndrome
  3. G-SCF Phase 3 · First People's Hospital · Granulocyte Colony-stimulating Factor
  4. Granulocyte Colony-Stimulating Factor(G-CSF) Phase 3 · Chinese Academy of · Myelodysplastic Syndrome
  5. TG-0054 combined with G-CSF Phase 2 · Structure Therapeutics · Multiple Myeloma
  6. PEG-rhG-CSF Approved · Chinese Academy of · Cervical Cancer
  7. G-CSF Unknown · Chinese Academy of · Intrauterine Adhesion
  8. G-CSF (Granulocyte colony-stimulating factor) Unknown · First People's Hospital · Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization

Related patents

Browse patents

  1. US 12421308

    Anti-G-CSF antibodies and uses thereof

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11813310

    Long-acting G-CSF for preventing neutropenia or reducing duration of neutropenia

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8183207

    Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is g-csf?

g-csf is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.